Page last updated: 2024-12-07

2,6-dichloroisonicotinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,6-dichloroisonicotinic acid: an ascorbate peroxidase antagonist; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,6-dichloroisonicotinic acid : A member of the class of pyridines that is isonicotinic acid which is substituted by chlorine at positions 2 and 6. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID94830
CHEMBL ID2447891
CHEBI ID73179
SCHEMBL ID56204
MeSH IDM0207542

Synonyms (48)

Synonym
AC-1716
2,6-dichloro-isonicotinic acid
5398-44-7
nsc4466
nsc-4466
4-pyridinecarboxylic acid, 2,6-dichloro-
pyridine-4-carboxylic acid, 2,6-dichloro-
ENAMINE_005327 ,
2,6-dichloroisonicotinic acid
inchi=1/c6h3cl2no2/c7-4-1-3(6(10)11)2-5(8)9-4/h1-2h,(h,10,11
2,6-dichloropyridine-4-carboxylic acid, 98%
STK503779
2,6-dichloropyridine-4-carboxylic acid
D3345
AKOS000271120
HMS1409C03
A7843
2,6-dichloroisonicotinic acid;2,6-dichloro-isonicotinic acid
2,6-dichloroisonicotinicacid
2,6-dichloro-4-pyridinecarboxylic acid
ai3-19387
nsc 4466
CHEBI:73179 ,
FT-0610616
PS-3149
AB05154
CHEMBL2447891
SCHEMBL56204
SRI-4127-04
2,6-dichloroisonicotinoic acid
J-400214
AC-907/25004488
2,6-dichloroisonicotinic acid #
pyridine-4-carboxilic acid, 2, 6-dichloro-
mfcd00234147
DTXSID20202286
F8880-0154
CS-W007536
Z56899064
BBL104410
SY012339
2,6-dichloro-4-pyridine carboxylic acid
Q27140359
AM9925
JKP ,
NCGC00339059-01
EN300-17194
HY-W007536

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response and time course experiments revealed a similar pattern of transcript accumulation and lipoxygenase activity in BTH-treated rice leaves."( Characterization of RCI-1, a chloroplastic rice lipoxygenase whose synthesis is induced by chemical plant resistance activators.
Dudler, R; Schaffrath, U; Zabbai, F, 2000
)
0.31
"Soil drenches of SA and INA and root dip application of SA and BTH inhibited nematode reproduction, at specific dosage ranges, without affecting plant growth."( Systemic acquired resistance activation in solanaceous crops as a management strategy against root-knot nematodes.
Molinari, S, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitorAn EC 1.11.1.* (peroxidases) inhibitor that inhibits the action of L-ascorbate peroxidase (EC 1.11.1.11).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
organochlorine compoundAn organochlorine compound is a compound containing at least one carbon-chlorine bond.
monocarboxylic acidAn oxoacid containing a single carboxy group.
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's11 (29.73)18.2507
2000's17 (45.95)29.6817
2010's8 (21.62)24.3611
2020's1 (2.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.55

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.55 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index20.59 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.55)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]